http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 10:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html <p align="left"><em>Issued on behalf of Conexeu Sciences Inc.</em></p> <p align="left"><em>A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.</em></p> <p align="left">NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin, http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html Tue, 16 Jun 2026 10:30:00 -0400 CNXU IART MDXG ORGO VCEL http://www.streetinsider.com/Press+Releases/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html <p align="left">PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.</p> <p align="left">A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under <a href="https://www.globenewswire.com/Tracker?data=_JCkJ_x7oYSqj4iMrhhtIwGHbfKakpX0a9hTcaJAyVA0PDmWQP5QP-zN7jEk0-TxM01j5kL0rSMu1oDLm16pYQle9dxQA4g9yGZkjGf5JegoyHO6C92Gvads9z9S-7lWY17fDEx_-KFG7gAZrRuzrQ==" rel="nofollow" target="_blank">EVENTS &amp; PRESENTATIONS</a>.</p> <p align="left"><strong>About Integra LifeSciences</strong><br />Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful http://www.streetinsider.com/Press+Releases/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html Mon, 15 Jun 2026 08:30:00 -0400 IART IART http://www.streetinsider.com/Press+Releases/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html <p align="left">PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.</p> <p align="left">A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under <a href="https://www.globenewswire.com/Tracker?data=_JCkJ_x7oYSqj4iMrhhtIwGHbfKakpX0a9hTcaJAyVA0PDmWQP5QP-zN7jEk0-TxM01j5kL0rSMu1oDLm16pYQle9dxQA4g9yGZkjGf5JegoyHO6C92Gvads9z9S-7lWY17fDEx_-KFG7gAZrRuzrQ==" rel="nofollow" target="_blank">EVENTS &amp; PRESENTATIONS</a>.</p> <p align="left"><strong>About Integra LifeSciences</strong><br />Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful http://www.streetinsider.com/Press+Releases/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html Mon, 15 Jun 2026 08:30:00 -0400 IART IART http://www.streetinsider.com/Globe+Newswire/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html <p align="left">PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.</p> <p align="left">A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under <a href="https://www.globenewswire.com/Tracker?data=_JCkJ_x7oYSqj4iMrhhtIwGHbfKakpX0a9hTcaJAyVA0PDmWQP5QP-zN7jEk0-TxM01j5kL0rSMu1oDLm16pYQle9dxQA4g9yGZkjGf5JegoyHO6C92Gvads9z9S-7lWY17fDEx_-KFG7gAZrRuzrQ==" rel="nofollow" target="_blank">EVENTS &amp; PRESENTATIONS</a>.</p> <p align="left"><strong>About Integra LifeSciences</strong><br />Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful http://www.streetinsider.com/Globe+Newswire/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html Mon, 15 Jun 2026 08:30:00 -0400 IART IART http://www.streetinsider.com/Globe+Newswire/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html <p align="left">PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.</p> <p align="left">A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under <a href="https://www.globenewswire.com/Tracker?data=_JCkJ_x7oYSqj4iMrhhtIwGHbfKakpX0a9hTcaJAyVA0PDmWQP5QP-zN7jEk0-TxM01j5kL0rSMu1oDLm16pYQle9dxQA4g9yGZkjGf5JegoyHO6C92Gvads9z9S-7lWY17fDEx_-KFG7gAZrRuzrQ==" rel="nofollow" target="_blank">EVENTS &amp; PRESENTATIONS</a>.</p> <p align="left"><strong>About Integra LifeSciences</strong><br />Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful http://www.streetinsider.com/Globe+Newswire/Integra+LifeSciences+to+Present+at+the+2026+Truist+Securities+MedTech+Conference/26644702.html Mon, 15 Jun 2026 08:30:00 -0400 IART IART http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Press+Releases/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Globe+Newswire/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Globe+Newswire/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN http://www.streetinsider.com/Globe+Newswire/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html <p><strong>Issued on behalf of Conexeu Sciences Inc.</strong></p><p align="left">NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=s02fupgOkYBxjoRQYi6_Mtg0mh73_8fezLnRs6C8ccNeiZ1JBuI-EpNhgaTI5OdKipKrTEBxdu6xJrHFgD3Z8RUbeKJGPKBJj2GjLom9F1E=" rel="nofollow" target="_blank">Equity Insider</a> News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (Nasdaq: CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further http://www.streetinsider.com/Globe+Newswire/A+Fresh+FDA+Catalyst+Is+Putting+Regenerative+Wound+Care+in+Focus/26621787.html Tue, 09 Jun 2026 09:54:59 -0400 CNXU CNXU CNXU IART IART MDXG MDXG SNN SNN